STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.
Stephen D'AmicoVarvara KirillovOleksi PetrenkoNancy C ReichPublished in: bioRxiv : the preprint server for biology (2023)
studies demonstrate that STAT3 responsive program is an inherent part of oncogenic KRAS outcome.